Contact
      Please use this form to send email to PR contact of this press release:
      
      AzurRx BioPharma and Mayoly-Spindler Announce Positive MS1819-SD Phase II Data in Exocrine Pancreatic Insufficiency (EPI)
    
      TO:
      
      
      
      
      
      
      
    
      Please use this form to send email to PR contact of this press release:
      
      AzurRx BioPharma and Mayoly-Spindler Announce Positive MS1819-SD Phase II Data in Exocrine Pancreatic Insufficiency (EPI)
    
      TO: